Diversity and Inclusion in Cancer Care and Clinical Trials

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 60 Minutes

A variety of factors contribute to disparities in clinical trial participation and cancer care. In this webcast, expert faculty describe barriers related to access, protocols, attitudes, and financial issues and how they impact participation of underserved populations in clinical trials and cancer care. Faculty will share strategies to overcome those shortcomings and how available tools can be used to help reduce disparities. Through this education, advanced practice providers will better recognize patients who face challenges in receiving the appropriate care, and how to mitigate those issues and improve diversity and inclusion of patients in underserved populations.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Recognize the impact of cancer health disparities on patients from underserved populations

2. Discover institutional and provider strategies to improve access to cancer care and mitigate financial toxicity in patients undergoing cancer treatment

3. Describe the current state of cancer clinical trials and identify methods to improve participation from underserved populations

4. Identify resources patients can use to decrease financial toxicity and optimize their access to cancer treatments and clinical trials

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
09/02/2022
Course expires: 
09/02/2023
Cost:
$0.00
Rating: 
0

Faculty

Brenda Lormil, MSN, FNP-C

Brenda Lormil currently serves as the Equity Nurse Practitioner at the Massachusetts General Hospital Cancer Center, Boston MA. She provides patient-centered care to underserved populations while helping them navigate the complexities of Phase 1 Clinical Trial enrollment. Her role provides the unique opportunity to work alongside colleagues and other passionate members of the MGH community to find creative ways to provide equitable access and quality delivery of care to some of the most vulnerable populations affected by cancer.

 

Beverly Moy, MD, MPH

Dr. Beverly Moy is the Clinical Director of the Breast Oncology Program, Director of Cancer Equity, and a medical oncologist at the Massachusetts General Hospital Cancer Center. She is an Associate Professor of Medicine at Harvard Medical School. Dr. Moy’s research interests include breast cancer clinical trials and cancer equity.

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Brenda Lormil and Dr Beverly Moy  Have no relevant disclosures

Available Credit

  • 1.00 AMA PRA Category 1 Credit
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form.

 

Required Hardware/software

 

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

 

DISCLOSURE OF UNLABELED USE:

Horizon CME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.